Corpus ID: 2023017

REVERSE PHARMACOLOGY: A NEW APPROACH TO DRUG DEVELOPMENT

@article{Saxena2015REVERSEPA,
  title={REVERSE PHARMACOLOGY: A NEW APPROACH TO DRUG DEVELOPMENT},
  author={A. Saxena},
  journal={International journal of sciences},
  year={2015}
}
  • A. Saxena
  • Published 2015
  • Biology
  • International journal of sciences
The pharmaceutical sector has traditionally been a vibrant, innovation-driven and highly successful component of global industry. A confluence of spectacular advances in chemistry, molecular biology, genomics and chemical technology and the cognate fields of spectroscopy, chromatography and crystallography led to the discovery and development of numerous novel therapeutic agents for the treatment of a wide spectrum of diseases. To facilitate this process, scientists launched a significant and… Expand
1 Citations

Figures and Tables from this paper

References

SHOWING 1-10 OF 35 REFERENCES
Nature's medicines: traditional knowledge and intellectual property management. Case studies from the National Institutes of Health (NIH), USA.
TLDR
This article reviews the forty years of cumulative experience at the National Institutes of Health in natural products drug discovery and presents three major cooperative programs, the legal mechanisms for cooperation and illustrative case studies from these programs. Expand
The evolving role of natural products in drug discovery
TLDR
Recent technological advances that help to address issues such as the lack of compatibility of traditional natural-product extract libraries with high-throughput screening and unrealized expectations from current lead-generation strategies have led to a renewed interest in natural products in drug discovery. Expand
Ayurveda and natural products drug discovery
This review attempts to portray the discovery and development of medicine from galenical to genomical, with a focus on the potential and role of ayurveda. Natural products, including plants, animalsExpand
Ethnopharmacology and systems biology: a perfect holistic match.
TLDR
Metabolomics will be a major tool in recognizing compounds connected with activity in the traditional medicines, and will also be very useful in recognizing the effect on the test organism, which can be the patient in case of clinical trials with well established traditional medicines. Expand
Should Pharmacogenomic Studies be Required for New Drug Approval?
TLDR
It is contention that minimal pharmacogenetic testing should be required for all new drug applications to the Food and Drug Administration, and this would include a requirement for germline DNA to be prospectively collected from all subjects participating in preapproval clinical trials. Expand
Reverse pharmacological correlates of ayurvedic drug actions
TLDR
The credit for kindling the interest of Indian chemists and pharmacologists in medicinal plants should rightfully go to Sir Ram Nath Chopra, who has been acclaimed as the ‘Father of Indian Pharmacology’. Expand
Ethnopharmacology in vaccine adjuvant discovery.
TLDR
The article indicates challenges in selection of herbal drugs for such bioprospecting and suggests that ethnopharmacology in contrast to random screening approach, which will be more cost and time effective. Expand
Modulating TNF-alpha signaling with natural products.
TLDR
Small-molecule drugs that can regulate TNF-alpha levels or activity might provide a cost-effective alternative to protein-based therapeutics. Expand
Qinghaosu (artemisinin): an antimalarial drug from China
TLDR
Derivatives of QHS, such as dihydroqinghaosu, artemether, and the water-soluble sodium artesunate, appear to be more potent than QHS itself, and offer promise as a totally new class of antimalarials. Expand
Pancreatic lipase inhibitors from natural sources: unexplored potential.
TLDR
Various extracts and secondary metabolites from plants and microbial origin with PL inhibitory activity that can be focused for drug development programs are reviewed. Expand
...
1
2
3
4
...